These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies. Kuschyk J; Müller-Leisse J; Duncker D; Tülümen E; Fastenrath F; Fastner C; Kruska M; Akin I; Liebe V; Borggrefe M; Veltmann C; Rudic B Int J Cardiol; 2021 Jan; 323():100-105. PubMed ID: 32871189 [TBL] [Abstract][Full Text] [Related]
14. RNA-based therapies for genodermatoses. Bornert O; Peking P; Bremer J; Koller U; van den Akker PC; Aartsma-Rus A; Pasmooij AM; Murauer EM; Nyström A Exp Dermatol; 2017 Jan; 26(1):3-10. PubMed ID: 27376675 [TBL] [Abstract][Full Text] [Related]
15. Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Castaño A; Drachman BM; Judge D; Maurer MS Heart Fail Rev; 2015 Mar; 20(2):163-78. PubMed ID: 25408161 [TBL] [Abstract][Full Text] [Related]
16. Gene and Cell Therapy for Cardiac Arrhythmias. Ravindran D; Kok C; Farraha M; Selvakumar D; Clayton ZE; Kumar S; Chong J; Kizana E Clin Ther; 2020 Oct; 42(10):1911-1922. PubMed ID: 32988632 [TBL] [Abstract][Full Text] [Related]
17. Pregnancy, cardiomyopathies, and genetics. Van Tintelen JP; Pieper PG; Van Spaendonck-Zwarts KY; Van Den Berg MP Cardiovasc Res; 2014 Mar; 101(4):571-8. PubMed ID: 24451172 [TBL] [Abstract][Full Text] [Related]